PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930037
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930037
The global surgical sutures market is witnessing steady growth driven by the rising number of surgical procedures, increasing prevalence of chronic diseases, and continuous advancements in suturing technologies. In 2025, the global surgical sutures market size was valued at USD 6.03 billion. The market is projected to grow from USD 6.42 billion in 2026 to USD 11.52 billion by 2034, registering a CAGR of 7.57% during the forecast period (2026-2034).
North America dominated the surgical sutures market with a 39.44% share in 2025, supported by a high volume of surgeries, advanced healthcare infrastructure, and strong presence of key market players.
Surgical sutures are medical devices used to close wounds and ligate blood vessels during or after surgical procedures. These products are extensively used in major surgeries such as cesarean sections, joint replacements, cardiovascular surgeries, and minor procedures including dental and ophthalmic surgeries. The growing incidence of road accidents, orthopedic injuries, and chronic disorders has significantly increased surgical volumes worldwide, thereby boosting demand for surgical sutures.
Market Drivers
Rising Number of Surgical Procedures
The increasing number of orthopedic, cardiovascular, gynecological, and cosmetic surgeries is a major factor driving market growth. For instance, data from the American College of Rheumatology (February 2023) indicates that approximately 790,000 knee replacement and 450,000 hip replacement surgeries are performed annually in the U.S.
Additionally, according to the CDC, 1,174,545 cesarean deliveries were recorded in the U.S. in 2021, accounting for 32.1% of all births. The expanding geriatric population, which is more prone to arthritis, fractures, and cardiovascular conditions, is further increasing surgical intervention rates and supporting market expansion.
Technological Advancements in Sutures
The introduction of advanced sutures, including knotless, elastic, and bio-composite sutures, is improving surgical outcomes and driving adoption. These sutures enable faster wound healing, reduced infection risk, and enhanced tensile strength. Continuous R&D investments and regulatory approvals for innovative products are positively influencing market growth.
Market Trends
Introduction of Advanced and Smart Sutures
One of the key trends in the market is the adoption of knotless and technologically advanced sutures designed to address unmet clinical needs. These sutures can deliver drugs, detect infections, and support efficient wound closure.
For instance, the U.S. FDA granted 510(k) clearance to several knotless suture systems, including Anika Therapeutics' X-Twist and Smith & Nephew's HELICOIL knotless sutures. Such advancements are enabling companies to strengthen their market position while expanding product portfolios.
Restraining Factors
Competition from Alternative Wound Closure Products
The availability of alternative wound care products such as surgical staplers poses a challenge to market growth. Staplers offer faster wound closure and reduced operation time. In addition, concerns related to surgical site infections (SSIs) associated with sutures and lack of reimbursement policies in emerging economies may limit adoption. According to NCBI data, approximately 5% of surgical patients develop SSIs annually, which impacts surgeon preference for sutures in certain procedures.
By Product Type
The market is segmented into absorbable and non-absorbable sutures.
The absorbable segment dominated with a 64.30% share in 2026, owing to faster healing, high tensile strength, and reduced need for stitch removal. Regulatory support further strengthens this segment's dominance.
By Form
Based on form, the market is divided into synthetic and natural sutures.
The synthetic segment accounted for 78.31% market share in 2026, attributed to lower hypersensitivity reactions and higher adoption by healthcare professionals.
By Application
The orthopedics segment led the market with a 27.40% share in 2026, driven by a rising number of joint replacement and fracture repair surgeries. Gynecology and cardiology also contribute significantly due to increasing cesarean and bypass procedures.
By End User
The hospitals & ASCs segment dominated with a 71.15% share in 2026, supported by high surgical volumes, advanced facilities, and skilled surgeons.
Competitive Landscape
Key players include B. Braun SE, Ethicon U.S. LLC, Medtronic, Smith & Nephew, and Coloplast A/S. These companies focus on product innovation, capacity expansion, and strategic launches to strengthen their global presence.
Conclusion
In conclusion, the global surgical sutures market is projected to grow steadily from USD 6.03 billion in 2025 to USD 11.52 billion by 2034. Rising surgical volumes, technological advancements in suturing devices, and increasing geriatric population are the key growth drivers. Although competition from alternative wound closure products and infection-related concerns pose challenges, continuous innovation and expanding healthcare infrastructure worldwide are expected to sustain long-term market growth.
Segmentation
By Product Type
By Form
By Application
By End-user
By Geography